Heat-shock proteins in cardiovascular disease

Advances in Clinical Chemistry

Volumn 54, Issue , 2011, Pages 1-43

  Madrigal Matute, Julio ^a   Martin Ventura, Jose Luis ^a   Blanco Colio, Luis Miguel ^a   Egido, Jesus ^a   Michel, Jean Baptiste ^b   Meilhac, Olivier ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b BICHAT HOSPITAL   (France)

Author keywords

Atherosclerosis; Atherothrombosis; Gene therapy; Heat shock protein; Lipoprotein; Plaque stability

Indexed keywords

BIOLOGICAL MARKER; HEAT SHOCK PROTEIN;

ANIMAL; ATHEROSCLEROSIS; BOOK; DRUG ANTAGONISM; HUMAN; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; HEAT-SHOCK PROTEINS; HUMANS;

EID: 79953876832     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387025-4.00001-7     Document Type: Book

References (243)

1. Chen Y., Voegeli T.S., Liu P.P., Noble E.G., Currie R.W. Heat shock paradox and a new role of heat shock proteins and their receptors as anti-inflammation targets. Inflamm. Allergy Drug Targets 2007, 6:91-100.
2. Ritossa F. Discovery of the heat shock response. Cell Stress Chaperones 1996, 1:97-98.
3. Tissieres A., Mitchell H.K., Tracy U.M. Protein synthesis in salivary glands of Drosophila melanogaster: relation to chromosome puffs. J. Mol. Biol. 1974, 84:389-398.
4. Ranford J.C., Henderson B. Chaperonins in disease: mechanisms, models, and treatments. Mol. Pathol. 2002, 55:209-213.
5. Parcellier A., Gurbuxani S., Schmitt E., Solary E., Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem. Biophys. Res. Commun. 2003, 304:505-512.
6. Mounier N., Arrigo A.P. Actin cytoskeleton and small heat shock proteins: how do they interact?. Cell Stress Chaperones 2002, 7:167-176.
7. Ghayour-Mobarhan M., Rahsepar A.A., Tavallaie S., Rahsepar S., Ferns G.A. The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies. Adv. Clin. Chem. 2009, 48:27-72.
8. Latchman D.S. Heat shock proteins and cardiac protection. Cardiovasc. Res. 2001, 51:637-646.
9. DeFranco D.B., Ho L., Falke E., Callaway C.W. Small molecule activators of the heat shock response and neuroprotection from stroke. Curr. Atheroscler. Rep. 2004, 6:295-300.
10. Kampinga H.H., Hageman J., Vos M.J., Kubota H., Tanguay R.M., Bruford E.A., et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 2009, 14:105-111.
11. Lu X., Kakkar V. The role of heat shock protein (HSP) in atherosclerosis: pathophysiology and clinical opportunities. Curr. Med. Chem. 2010, 17:957-973.
12. Amberger A., Maczek C., Jurgens G., Michaelis D., Schett G., Trieb K., et al. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones 1997, 2:94-103.
13. Shan Z.X., Lin Q.X., Deng C.Y., Zhu J.N., Mai L.P., Liu J.L., et al. miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS Lett. 2010, 584:3592-3600.
14. Kleindienst R., Xu Q., Willeit J., Waldenberger F.R., Weimann S., Wick G. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am. J. Pathol. 1993, 142:1927-1937.
15. Chandra D., Choy G., Tang D.G. Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3. J. Biol. Chem. 2007, 282:31289-31301.
16. Kim S.C., Stice J.P., Chen L., Jung J.S., Gupta S., Wang Y., et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ. Res. 2009, 105:1186-1195.
17. Deocaris C.C., Kaul S.C., Wadhwa R. On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60. Cell Stress Chaperones 2006, 11:116-128.
18. Czarnecka A.M., Campanella C., Zummo G., Cappello F. Heat shock protein 10 and signal transduction: a "capsula eburnea" of carcinogenesis?. Cell Stress Chaperones 2006, 11:287-294.
19. Sigal L.H., Williams S., Soltys B., Gupta R. H9724, a monoclonal antibody to Borrelia burgdorferi's flagellin, binds to heat shock protein 60 (HSP60) within live neuroblastoma cells: a potential role for HSP60 in peptide hormone signaling and in an autoimmune pathogenesis of the neuropathy of Lyme disease. Cell. Mol. Neurobiol. 2001, 21:477-495.
20. Hirono S., Dibrov E., Hurtado C., Kostenuk A., Ducas R., Pierce G.N. Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60. Circ. Res. 2003, 93:710-716.
21. Chen W., Syldath U., Bellmann K., Burkart V., Kolb H. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J. Immunol. 1999, 162:3212-3219.
22. Erkkila L., Laitinen K., Haasio K., Tiirola T., Jauhiainen M., Lehr H.A., et al. Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JBom mice during Chlamydia pneumoniae infection. Atherosclerosis 2004, 177:321-328.
23. Xu Q., Schett G., Perschinka H., Mayr M., Egger G., Oberhollenzer F., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000, 102:14-20.
24. Pockley A.G., Wu R., Lemne C., Kiessling R., de F.U., Frostegard J. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 2000, 36:303-307.
25. Mandal K., Afzal A.R., Brecker S.J., Poloniecki J., Xu Q., Jahangiri M. Association of serum soluble heat shock protein 60 with toll-like receptor 4 polymorphism and severity of coronary artery disease. Heart 2006, 92:683-685.
26. Zhang X., He M., Cheng L., Chen Y., Zhou L., Zeng H., et al. Elevated heat shock protein 60 levels are associated with higher risk of coronary heart disease in Chinese. Circulation 2008, 118:2687-2693.
27. Rothenbacher D., Hoffmeister A., Bode G., Miller M., Koenig W., Brenner H. Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids. Atherosclerosis 2001, 156:193-199.
28. Lewthwaite J., Owen N., Coates A., Henderson B., Steptoe A. Circulating human heat shock protein 60 in the plasma of British civil servants: relationship to physiological and psychosocial stress. Circulation 2002, 106:196-201.
29. Schett G., Metzler B., Kleindienst R., Amberger A., Recheis H., Xu Q., et al. Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc. Res. 1999, 42:685-695.
30. Xu Q., Kiechl S., Mayr M., Metzler B., Egger G., Oberhollenzer F., et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 1999, 100:1169-1174.
31. Zhu J., Quyyumi A.A., Rott D., Csako G., Wu H., Halcox J., et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001, 103:1071-1075.
32. Hoppichler F., Lechleitner M., Traweger C., Schett G., Dzien A., Sturm W., et al. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 1996, 126:333-338.
33. Veres A., Fust G., Smieja M., McQueen M., Horvath A., Yi Q., et al. Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events. Circulation 2002, 106:2775-2780.
34. Kervinen H., Huittinen T., Vaarala O., Leinonen M., Saikku P., Manninen V., et al. Antibodies to human heat shock protein 60, hypertension and dyslipidemia. A study of joint effects on coronary risk. Atherosclerosis 2003, 169:339-344.
35. Mayr M., Metzler B., Kiechl S., Willeit J., Schett G., Xu Q., et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999, 99:1560-1566.
36. Burian K., Kis Z., Virok D., Endresz V., Prohaszka Z., Duba J., et al. Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 2001, 103:1503-1508.
37. Heltai K., Kis Z., Burian K., Endresz V., Veres A., Ludwig E., et al. Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease. Atherosclerosis 2004, 173:339-346.
38. Hoshida S., Nishino M., Tanouchi J., Kishimoto T., Yamada Y. Acute Chlamydia pneumoniae infection with heat-shock-protein-60-related response in patients with acute coronary syndrome. Atherosclerosis 2005, 183:109-112.
39. Zhu J., Katz R.J., Quyyumi A.A., Canos D.A., Rott D., Csako G., et al. Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation 2004, 109:36-41.
40. Huittinen T., Leinonen M., Tenkanen L., Manttari M., Virkkunen H., Pitkanen T., et al. Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arterioscler. Thromb. Vasc. Biol. 2002, 22:431-437.
41. Madrigal-Matute J., Lopez-Franco O., Blanco-Colio L.M., Munoz-Garcia B., Ramos-Mozo P., Ortega L., et al. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis. Cardiovasc. Res. 2010, 86:330-337.
42. Morris S.D., Cumming D.V., Latchman D.S., Yellon D.M. Specific induction of the 70-kD heat stress proteins by the tyrosine kinase inhibitor herbimycin-A protects rat neonatal cardiomyocytes. A new pharmacological route to stress protein expression?. J. Clin. Invest. 1996, 97:706-712.
43. Xu Q., Schett G., Li C., Hu Y., Wick G. Mechanical stress-induced heat shock protein 70 expression in vascular smooth muscle cells is regulated by Rac and Ras small G proteins but not mitogen-activated protein kinases. Circ. Res. 2000, 86:1122-1128.
44. Ivan L., Antohe F. Hyperlipidemia induces endothelial-derived foam cells in culture. J. Recept. Signal Transduct. Res. 2010, 30:106-114.
45. Zhu W.M., Roma P., Pirillo A., Pellegatta F., Catapano A.L. Oxidized LDL induce hsp70 expression in human smooth muscle cells. FEBS Lett. 1995, 372:1-5.
46. Liu Y.N., Pan S.L., Peng C.Y., Huang D.Y., Guh J.H., Kuo S.C., et al. YC-1 induces heat shock protein 70 expression and prevents oxidized LDL-mediated apoptosis in vascular smooth muscle cells. Shock 2008, 30:274-279.
47. Johnson A.D., Berberian P.A., Tytell M., Bond M.G. Differential distribution of 70-kD heat shock protein in atherosclerosis. Its potential role in arterial SMC survival. Arterioscler. Thromb. Vasc. Biol. 1995, 15:27-36.
48. Gill R.R., Gbur C.J., Fisher B.J., Hess M.L., Fowler A.A., Kukreja R.C., et al. Heat shock provides delayed protection against oxidative injury in cultured human umbilical vein endothelial cells. J. Mol. Cell. Cardiol. 1998, 30:2739-2749.
49. Asea A., Kraeft S.K., Kurt-Jones E.A., Stevenson M.A., Chen L.B., Finberg R.W., et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 2000, 6:435-442.
50. Yao Y., Watson A.D., Ji S., Bostrom K.I. Heat shock protein 70 enhances vascular bone morphogenetic protein-4 signaling by binding matrix Gla protein. Circ. Res. 2009, 105:575-584.
51. George J., Greenberg S., Barshack I., Singh M., Pri-Chen S., Laniado S., et al. Accelerated intimal thickening in carotid arteries of balloon-injured rats after immunization against heat shock protein 70. J. Am. Coll. Cardiol. 2001, 38:1564-1569.
52. Pockley A.G., Georgiades A., Thulin T., de F.U., Frostegard J. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 2003, 42:235-238.
53. Zhu J., Quyyumi A.A., Wu H., Csako G., Rott D., Zalles-Ganley A., et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1055-1059.
54. Martin-Ventura J.L., Leclercq A., Blanco-Colio L.M., Egido J., Rossignol P., Meilhac O., et al. Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation. Atherosclerosis 2007, 194:334-341.
55. Zhang X., Xu Z., Zhou L., Chen Y., He M., Cheng L., et al. Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome. Cell Stress Chaperones 2010, 15:675-686.
56. Herz I., Rosso R., Roth A., Keren G., George J. Serum levels of anti heat shock protein 70 antibodies in patients with stable and unstable angina pectoris. Acute Card. Care 2006, 8:46-50.
57. Martin-Ventura J.L., Nicolas V., Houard X., Blanco-Colio L.M., Leclercq A., Egido J., et al. Biological significance of decreased HSP27 in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1337-1343.
58. Santell L., Bartfeld N.S., Levin E.G. Identification of a protein transiently phosphorylated by activators of endothelial cell function as the heat-shock protein HSP27. A possible role for protein kinase C. Biochem. J. 1992, 284(Pt 3):705-710.
59. Martin J.L., Hickey E., Weber L.A., Dillmann W.H., Mestril R. Influence of phosphorylation and oligomerization on the protective role of the small heat shock protein 27 in rat adult cardiomyocytes. Gene Expr. 1999, 7:349-355.
60. Martin J.L., Mestril R., Hilal-Dandan R., Brunton L.L., Dillmann W.H. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 1997, 96:4343-4348.
61. De A.K., Kodys K.M., Yeh B.S., Miller-Graziano C. Exaggerated human monocyte IL-10 concomitant to minimal TNF-alpha induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an antiinflammatory stimulus. J. Immunol. 2000, 165:3951-3958.
62. Callahan T.E., Marins J., Welch W.J., Horn J.K. Heat shock attenuates oxidation and accelerates apoptosis in human neutrophils. J. Surg. Res. 1999, 85:317-322.
63. Zhou M., Lambert H., Landry J. Transient activation of a distinct serine protein kinase is responsible for 27-kDa heat shock protein phosphorylation in mitogen-stimulated and heat-shocked cells. J. Biol. Chem. 1993, 268:35-43.
64. Salinthone S., Tyagi M., Gerthoffer W.T. Small heat shock proteins in smooth muscle. Pharmacol. Ther. 2008, 119:44-54.
65. Preville X., Salvemini F., Giraud S., Chaufour S., Paul C., Stepien G., et al. Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp. Cell Res. 1999, 247:61-78.
66. Voegeli T.S., Currie R.W. siRNA knocks down Hsp27 and increases angiotensin II-induced phosphorylated NF-kappaB p65 levels in aortic smooth muscle cells. Inflamm. Res. 2009, 58:336-343.
67. Sheth K., De A., Nolan B., Friel J., Duffy A., Ricciardi R., et al. Heat shock protein 27 inhibits apoptosis in human neutrophils. J. Surg. Res. 2001, 99:129-133.
68. Martin-Ventura J.L., Duran M.C., Blanco-Colio L.M., Meilhac O., Leclercq A., Michel J.B., et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004, 110:2216-2219.
69. Dybdahl B., Slordahl S.A., Waage A., Kierulf P., Espevik T., Sundan A. Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 2005, 91:299-304.
70. Ghayour-Mobarhan M., Sahebkar A., Parizadeh S.M., Moohebati M., Tavallaie S., Rezakazemi-Bajestani S.M., et al. Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. Int. J. Exp. Pathol. 2008, 89:209-215.
71. Shams S., Shafi S., Bodman-Smith K., Williams P., Mehta S., Ferns G.A. Anti-heat shock protein-27 (Hsp-27) antibody levels in patients with chest pain: association with established cardiovascular risk factors. Clin. Chim. Acta 2008, 395:42-46.
72. Joseph K., Tholanikunnel B.G., Kaplan A.P. Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90. Int. Immunopharmacol. 2002, 2:1851-1859.
73. Huang H., Lee W.C., Lin J.H., Jian S.C., Mao S.J., Yang P.C., et al. Molecular cloning and characterization of porcine cDNA encoding a 90-kDa heat shock protein and its expression following hyperthermia. Gene 1999, 226:307-315.
74. Stepp D.W., Ou J., Ackerman A.W., Welak S., Klick D., Pritchard K.A. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H750-H759.
75. Lin L.Y., Lin C.Y., Su T.C., Liau C.S. Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett. 2004, 574:106-110.
76. Sun J., Liao J.K. Induction of angiogenesis by heat shock protein 90 mediated by protein kinase Akt and endothelial nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2238-2244.
77. Luikart S.D., Panoskaltsis-Mortari A., Hinkel T., Perri R.T., Gupta K., Oegema T.R., et al. Mactinin, a fragment of cytoskeletal alpha-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation. BMC Cell Biol. 2009, 10:60.
78. Liao D.F., Jin Z.G., Baas A.S., Daum G., Gygi S.P., Aebersold R., et al. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J. Biol. Chem. 2000, 275:189-196.
79. Chung S.W., Lee J.H., Choi K.H., Park Y.C., Eo S.K., Rhim B.Y., et al. Extracellular heat shock protein 90 induces interleukin-8 in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2009, 378:444-449.
80. Shi Y., Mosser D.D., Morimoto R.I. Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev. 1998, 12:654-666.
81. Businaro R., Profumo E., Tagliani A., Buttari B., Leone S., D'Amati G., et al. Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis 2009, 207:74-83.
82. Benjamin I.J., McMillan D.R. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ. Res. 1998, 83:117-132.
83. Galea-Lauri J., Richardson A.J., Latchman D.S., Katz D.R. Increased heat shock protein 90 (hsp90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-alpha and cycloheximide: a possible role in immunopathology. J. Immunol. 1996, 157:4109-4118.
84. Dupont A., Chwastyniak M., Beseme O., Guihot A.L., Drobecq H., Amouyel P., et al. Application of saturation dye 2D-DIGE proteomics to characterize proteins modulated by oxidized low density lipoprotein treatment of human macrophages. J. Proteome Res. 2008, 7:3572-3582.
85. Clerget M., Polla B.S. Erythrophagocytosis induces heat shock protein synthesis by human monocytes-macrophages. Proc. Natl. Acad. Sci. USA 1990, 87:1081-1085.
86. Matz P., Weinstein P., States B., Honkaniemi J., Sharp F.R. Subarachnoid injections of lysed blood induce the hsp70 stress gene and produce DNA fragmentation in focal areas of the rat brain. Stroke 1996, 27:504-512.
87. Palinski W., Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 2002, 16:1348-1360.
88. Chen H.F., Xie L.D., Xu C.S. Role of heat shock protein 27 phosphorylation in migration of vascular smooth muscle cells. Mol. Cell. Biochem. 2009, 327:1-6.
89. Vanmuylder N., Evrard L., Dourov N. Strong expression of heat shock proteins in growth plate cartilage, an immunohistochemical study of HSP28, HSP70 and HSP110. Anat. Embryol. (Berl) 1997, 195:359-362.
90. Hellings W.E., Peeters W., Moll F.L., Piers S.R., van S.J., Van der Spek P.J., et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010, 121:1941-1950.
91. Xiao Q., Mandal K., Schett G., Mayr M., Wick G., Oberhollenzer F., et al. Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study. Stroke 2005, 36:2571-2576.
92. Xu Q., Kleindienst R., Waitz W., Dietrich H., Wick G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J. Clin. Invest. 1993, 91:2693-2702.
93. Xu Q., Luef G., Weimann S., Gupta R.S., Wolf H., Wick G. Staining of endothelial cells and macrophages in atherosclerotic lesions with human heat-shock protein-reactive antisera. Arterioscler. Thromb. 1993, 13:1763-1769.
94. Kol A., Bourcier T., Lichtman A.H., Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Invest. 1999, 103:571-577.
95. Pockley A.G., Shepherd J., Corton J.M. Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol. Invest. 1998, 27:367-377.
96. Leger J.P., Smith F.M., Currie R.W. Confocal microscopic localization of constitutive and heat shock-induced proteins HSP70 and HSP27 in the rat heart. Circulation 2000, 102:1703-1709.
97. Berberian P.A., Myers W., Tytell M., Challa V., Bond M.G. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am. J. Pathol. 1990, 136:71-80.
98. Kardys I., Rifai N., Meilhac O., Michel J.B., Martin-Ventura J.L., Buring J.E., et al. Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study. Clin. Chem. 2008, 54:139-146.
99. Park H.K., Park E.C., Bae S.W., Park M.Y., Kim S.W., Yoo H.S., et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006, 114:886-893.
100. Rajaiah R., Moudgil K.D. Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmun. Rev. 2009, 8:388-393.
101. Perschinka H., Mayr M., Millonig G., Mayerl C., van der Zee R., Morrison S.G., et al. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1060-1065.
102. Zhang X., He M.A., Cheng L., Zhou L., Zeng H., Wang J., et al. Joint effects of antibody to heat shock protein 60, hypertension, and diabetes on risk of coronary heart disease in Chinese. Clin. Chem. 2008, 54:1046-1052.
103. Fehrenbach E., Northoff H. Free radicals, exercise, apoptosis, and heat shock proteins. Exerc. Immunol. Rev. 2001, 7:66-89.
104. Noble E.G., Milne K.J., Melling C.W. Heat shock proteins and exercise: a primer. Appl. Physiol. Nutr. Metab. 2008, 33:1050-1065.
105. Yang M., Wu T., Cheng L., Wang F., Wei Q., Tanguay R.M. Plasma antibodies against heat shock protein 70 correlate with the incidence and severity of asthma in a Chinese population. Respir. Res. 2005, 6:18.
106. Fust G., Beck Z., Banhegyi D., Kocsis J., Biro A., Prohaszka Z. Antibodies against heat shock proteins and cholesterol in HIV infection. Mol. Immunol. 2005, 42:79-85.
107. Figueredo A., Ibarra J.L., Rodriguez A., Molino A.M. Gomez-de la Concha E, Fernandez-Cruz A, et al. Increased serum levels of IgA antibodies to hsp70 protein in patients with diabetes mellitus: their relationship with vascular complications. Clin. Immunol. Immunopathol. 1996, 79:252-255.
108. Olejek A., Damasiewicz-Bodzek A., Bodzek P., Wielkoszynski T., Zamlynski J., Stoltny P., et al. Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma. Int. J. Gynecol. Cancer 2009, 19:1516-1520.
109. Demmer R.T., Desvarieux M. Periodontal infections and cardiovascular disease: the heart of the matter. J. Am. Dent. Assoc. 2006, 137(Suppl.):14S-20S.
110. Garcia-Arguinzonis M., Padro T., Lugano R., Llorente-Cortes V., Badimon L. Low-density lipoproteins induce heat shock protein 27 dephosphorylation, oligomerization, and subcellular relocalization in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1212-1219.
111. Rayner K., Chen Y.X., McNulty M., Simard T., Zhao X., Wells D.J., et al. Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A. Circ. Res. 2008, 103:133-141.
112. Zanini C., Pulera F., Carta F., Giribaldi G., Mandili G., Maule M.M., et al. Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing's sarcoma. Virchows Arch. 2008, 452:157-167.
113. Pei H., Zhu H., Zeng S., Li Y., Yang H., Shen L., et al. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J. Proteome Res. 2007, 6:2495-2501.
114. Langer R., Ott K., Specht K., Becker K., Lordick F., Burian M., et al. Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response. Clin. Cancer Res. 2008, 14:8279-8287.
115. Feinstein D.L., Galea E., Aquino D.A., Li G.C., Xu H., Reis D.J. Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation. J. Biol. Chem. 1996, 271:17724-17732.
116. Van M.W., Wielockx B., Mahieu T., Takada M., Taniguchi T., Sekikawa K., et al. HSP70 protects against TNF-induced lethal inflammatory shock. Immunity 2002, 16:685-695.
117. Ialenti A., Di M.P., D'Acquisto F., Pisano B., Maffia P., Grassia G., et al. Inhibition of cyclooxygenase-2 gene expression by the heat shock response in J774 murine macrophages. Eur. J. Pharmacol. 2005, 509:89-96.
118. Jo S.K., Ko G.J., Boo C.S., Cho W.Y., Kim H.K. Heat preconditioning attenuates renal injury in ischemic ARF in rats: role of heat-shock protein 70 on NF-kappaB-mediated inflammation and on tubular cell injury. J. Am. Soc. Nephrol. 2006, 17:3082-3092.
119. Zheng Z., Kim J.Y., Ma H., Lee J.E., Yenari M.A. Anti-inflammatory effects of the 70 kDa heat shock protein in experimental stroke. J. Cereb. Blood Flow Metab. 2008, 28:53-63.
120. Zugel U., Kaufmann S.H. Immune response against heat shock proteins in infectious diseases. Immunobiology 1999, 201:22-35.
121. van E.W., van der Zee R., Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat. Rev. Immunol. 2005, 5:318-330.
122. Ananthan J., Goldberg A.L., Voellmy R. Abnormal proteins serve as eukaryotic stress signals and trigger the activation of heat shock genes. Science 1986, 232:522-524.
123. Ali A., Bharadwaj S., O'Carroll R., Ovsenek N. HSP90 interacts with and regulates the activity of heat shock factor 1 in Xenopus oocytes. Mol. Cell. Biol. 1998, 18:4949-4960.
124. Smith D.F., Sullivan W.P., Marion T.N., Zaitsu K., Madden B., McCormick D.J., et al. Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70. Mol. Cell. Biol. 1993, 13:869-876.
125. Hohfeld J., Minami Y., Hartl F.U. Hip, a novel cochaperone involved in the eukaryotic Hsc70/Hsp40 reaction cycle. Cell 1995, 83:589-598.
126. Minami Y., Hohfeld J., Ohtsuka K., Hartl F.U. Regulation of the heat-shock protein 70 reaction cycle by the mammalian DnaJ homolog, Hsp40. J. Biol. Chem. 1996, 271:19617-19624.
127. Hutchison K.A., Stancato L.F., Owens-Grillo J.K., Johnson J.L., Krishna P., Toft D.O., et al. The 23-kDa acidic protein in reticulocyte lysate is the weakly bound component of the hsp foldosome that is required for assembly of the glucocorticoid receptor into a functional heterocomplex with hsp90. J. Biol. Chem. 1995, 270:18841-18847.
128. Baler R., Dahl G., Voellmy R. Activation of human heat shock genes is accompanied by oligomerization, modification, and rapid translocation of heat shock transcription factor HSF1. Mol. Cell. Biol. 1993, 13:2486-2496.
129. Sarge K.D., Murphy S.P., Morimoto R.I. Activation of heat shock gene transcription by heat shock factor 1 involves oligomerization, acquisition of DNA-binding activity, and nuclear localization and can occur in the absence of stress. Mol. Cell. Biol. 1993, 13:1392-1407.
130. Westwood J.T., Wu C. Activation of Drosophila heat shock factor: conformational change associated with a monomer-to-trimer transition. Mol. Cell. Biol. 1993, 13:3481-3486.
131. Shringarpure R., Grune T., Mehlhase J., Davies K.J. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J. Biol. Chem. 2003, 278:311-318.
132. Lee Y.H., Govinda B., Kim J.C., Kim T.I., Lee N.H., Lee J.C., et al. Oxidative stress resistance through blocking Hsp60 translocation followed by SAPK/JNK inhibition in aged human diploid fibroblasts. Cell Biochem. Funct. 2009, 27:35-39.
133. Lee Y.H., Lee J.C., Moon H.J., Jung J.E., Sharma M., Park B.H., et al. Differential effect of oxidative stress on the apoptosis of early and late passage human diploid fibroblasts: implication of heat shock protein 60. Cell Biochem. Funct. 2008, 26:502-508.
134. Xu Q., Schett G., Seitz C.S., Hu Y., Gupta R.S., Wick G. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ. Res. 1994, 75:1078-1085.
135. Bason C., Corrocher R., Lunardi C., Puccetti P., Olivieri O., Girelli D., et al. Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 2003, 362:1971-1977.
136. Polla B.S., Kantengwa S., Francois D., Salvioli S., Franceschi C., Marsac C., et al. Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc. Natl. Acad. Sci. USA 1996, 93:6458-6463.
137. Xu L., Giffard R.G. HSP70 protects murine astrocytes from glucose deprivation injury. Neurosci. Lett. 1997, 224:9-12.
138. Jacquier-Sarlin M.R., Fuller K., Dinh-Xuan A.T., Richard M.J., Polla B.S. Protective effects of hsp70 in inflammation. Experientia 1994, 50:1031-1038.
139. Stuhlmeier K.M. Activation and regulation of Hsp32 and Hsp70. Eur. J. Biochem. 2000, 267:1161-1167.
140. Pandey P., Saleh A., Nakazawa A., Kumar S., Srinivasula S.M., Kumar V., et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 2000, 19:4310-4322.
141. Beere H.M., Wolf B.B., Cain K., Mosser D.D., Mahboubi A., Kuwana T., et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2000, 2:469-475.
142. Saleh A., Srinivasula S.M., Balkir L., Robbins P.D., Alnemri E.S. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell Biol. 2000, 2:476-483.
143. Li C.Y., Lee J.S., Ko Y.G., Kim J.I., Seo J.S. Heat shock protein 70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation. J. Biol. Chem. 2000, 275:25665-25671.
144. Matsumori Y., Northington F.J., Hong S.M., Kayama T., Sheldon R.A., Vexler Z.S., et al. Reduction of caspase-8 and-9 cleavage is associated with increased c-FLIP and increased binding of Apaf-1 and Hsp70 after neonatal hypoxic/ischemic injury in mice overexpressing Hsp70. Stroke 2006, 37:507-512.
145. Ravagnan L., Gurbuxani S., Susin S.A., Maisse C., Daugas E., Zamzami N., et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 2001, 3:839-843.
146. Alcocer F., Whitley D., Salazar J., Jordan W., Bland K.I. Mutual exclusion of apoptosis and hsp70 in human vein intimal hyperplasia in vitro. J. Surg. Res. 2001, 96:75-80.
147. Wang J.H., Redmond H.P., Watson R.W., Condron C., Bouchier-Hayes D. Induction of heat shock protein 72 prevents neutrophil-mediated human endothelial cell necrosis. Arch. Surg. 1995, 130:1260-1265.
148. DeMeester S.L., Buchman T.G., Qiu Y., Jacob A.K., Dunnigan K., Hotchkiss R.S., et al. Heat shock induces IkappaB-alpha and prevents stress-induced endothelial cell apoptosis. Arch. Surg. 1997, 132:1283-1287.
149. Wong H.R., Mannix R.J., Rusnak J.M., Boota A., Zar H., Watkins S.C., et al. The heat-shock response attenuates lipopolysaccharide-mediated apoptosis in cultured sheep pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 1996, 15:745-751.
150. Bernardini C., Zannoni A., Turba M.E., Fantinati P., Tamanini C., Bacci M.L., et al. Heat shock protein 70, heat shock protein 32, and vascular endothelial growth factor production and their effects on lipopolysaccharide-induced apoptosis in porcine aortic endothelial cells. Cell Stress Chaperones 2005, 10:340-348.
151. Yenari M.A., Liu J., Zheng Z., Vexler Z.S., Lee J.E., Giffard R.G. Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann. NY Acad. Sci. 2005, 1053:74-83.
152. House S.D., Guidon P.T., Perdrizet G.A., Rewinski M., Kyriakos R., Bockman R.S., et al. Effects of heat shock, stannous chloride, and gallium nitrate on the rat inflammatory response. Cell Stress Chaperones 2001, 6:164-171.
153. Sato M., Fraga C., Das D.K. Induction of the expression of cardioprotective proteins after mild-to-moderate consumption of alcohol. Pathophysiology 2004, 10:139-145.
154. Chen Z.C., Wu W.S., Lin M.T., Hsu C.C. Protective effect of transgenic expression of porcine heat shock protein 70 on hypothalamic ischemic and oxidative damage in a mouse model of heatstroke. BMC Neurosci. 2009, 10:111.
155. Wang J.L., Ke D.S., Lin M.T. Heat shock pretreatment may protect against heatstroke-induced circulatory shock and cerebral ischemia by reducing oxidative stress and energy depletion. Shock 2005, 23:161-167.
156. Mirabelli F., Salis A., Perotti M., Taddei F., Bellomo G., Orrenius S. Alterations of surface morphology caused by the metabolism of menadione in mammalian cells are associated with the oxidation of critical sulfhydryl groups in cytoskeletal proteins. Biochem. Pharmacol. 1988, 37:3423-3427.
157. Liang P., MacRae T.H. Molecular chaperones and the cytoskeleton. J. Cell Sci. 1997, 110(Pt 13):1431-1440.
158. Miron T., Vancompernolle K., Vandekerckhove J., Wilchek M., Geiger B. A 25-kD inhibitor of actin polymerization is a low molecular mass heat shock protein. J. Cell Biol. 1991, 114:255-261.
159. Campisi D., Cutolo M., Carruba G., Lo C.M., Comito L., Granata O.M., et al. Evidence for soluble and nuclear site I binding of estrogens in human aorta. Atherosclerosis 1993, 103:267-277.
160. Lepedda A.J., Cigliano A., Cherchi G.M., Spirito R., Maggioni M., Carta F., et al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 2009, 203:112-118.
161. Chen Y., Currie R.W. Small interfering RNA knocks down heat shock factor-1 (HSF-1) and exacerbates pro-inflammatory activation of NF-kappaB and AP-1 in vascular smooth muscle cells. Cardiovasc. Res. 2006, 69:66-75.
162. Rousseau S., Houle F., Landry J., Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 1997, 15:2169-2177.
163. Gorska M.M., Liang Q., Stafford S.J., Goplen N., Dharajiya N., Guo L., et al. MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation. J. Exp. Med. 2007, 204:1637-1652.
164. Wang Z., Chen Y., Labinskyy N., Hsieh T.C., Ungvari Z., Wu J.M. Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts. Biochem. Biophys. Res. Commun. 2006, 346:367-376.
165. Gorman A.M., Szegezdi E., Quigney D.J., Samali A. Hsp27 inhibits 6-hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells. Biochem. Biophys. Res. Commun. 2005, 327:801-810.
166. Schepers H., Geugien M., van der Toorn M., Bryantsev A.L., Kampinga H.H., Eggen B.J., et al. HSP27 protects AML cells against VP-16-induced apoptosis through modulation of p38 and c-Jun. Exp. Hematol. 2005, 33:660-670.
167. Garrido C., Bruey J.M., Fromentin A., Hammann A., Arrigo A.P., Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J. 1999, 13:2061-2070.
168. Bruey J.M., Ducasse C., Bonniaud P., Ravagnan L., Susin S.A., Diaz-Latoud C., et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell Biol. 2000, 2:645-652.
169. O'Brien J.E., Ormont M.L., Shi Y., Wang D., Zalewski A., Mannion J.D. Early injury to the media after saphenous vein grafting. Ann. Thorac. Surg. 1998, 65:1273-1278.
170. Vayssier M., Polla B.S. Heat shock proteins chaperoning life and death. Cell Stress Chaperones 1998, 3:221-227.
171. Samali A., Orrenius S. Heat shock proteins: regulators of stress response and apoptosis. Cell Stress Chaperones 1998, 3:228-236.
172. Walsh K., Smith R.C., Kim H.S. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ. Res. 2000, 87:184-188.
173. Ingber D.E. Tensegrity II. How structural networks influence cellular information processing networks. J. Cell. Sci. 2003, 116:1397-1408.
174. Michel J.B. Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler. Thromb. Vasc. Biol. 2003, 23:2146-2154.
175. Rinaldi B., Romagnoli P., Bacci S., Carnuccio R., Maiuri M.C., Donniacuo M., et al. Inflammatory events in a vascular remodeling model induced by surgical injury to the rat carotid artery. Br. J. Pharmacol. 2006, 147:175-182.
176. Rayner K., Sun J., Chen Y.X., McNulty M., Simard T., Zhao X., et al. Heat shock protein 27 protects against atherogenesis via an estrogen-dependent mechanism: role of selective estrogen receptor beta modulation. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1751-1756.
177. Garcia-Cardena G., Fan R., Shah V., Sorrentino R., Cirino G., Papapetropoulos A., et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998, 392:821-824.
178. Conconi M., Petropoulos I., Emod I., Turlin E., Biville F., Friguet B. Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90. Biochem. J. 1998, 333(Pt 2):407-415.
179. Hogg N., Kalyanaraman B., Joseph J., Struck A., Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett. 1993, 334:170-174.
180. Hogg N., Struck A., Goss S.P., Santanam N., Joseph J., Parthasarathy S., et al. Inhibition of macrophage-dependent low density lipoprotein oxidation by nitric-oxide donors. J. Lipid Res. 1995, 36:1756-1762.
181. Rikitake Y., Hirata K., Kawashima S., Akita H., Yokoyama M. Inhibitory effect of inducible type nitric oxide synthase on oxidative modification of low density lipoprotein by vascular smooth muscle cells. Atherosclerosis 1998, 136:51-57.
182. Morrel E.M., Holland J.A., Pritchard K.A., Colton C.K., Stemerman M.B. Endothelial cell perturbation and low-density lipoprotein. Quantitative autoradiography. Ann. NY Acad. Sci. 1987, 516:412-417.
183. Chen J.X., Meyrick B. Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium. Lab. Invest. 2004, 84:182-190.
184. Fontana J., Fulton D., Chen Y., Fairchild T.A., McCabe T.J., Fujita N., et al. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ. Res. 2002, 90:866-873.
185. Russell K.S., Haynes M.P., Caulin-Glaser T., Rosneck J., Sessa W.C., Bender J.R. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release. J. Biol. Chem. 2000, 275:5026-5030.
186. Conconi M., Friguet B. Proteasome inactivation upon aging and on oxidation-effect of HSP 90. Mol. Biol. Rep. 1997, 24:45-50.
187. Conconi M., Szweda L.I., Levine R.L., Stadtman E.R., Friguet B. Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. Arch. Biochem. Biophys. 1996, 331:232-240.
188. Liu D.H., Yuan H.Y., Cao C.Y., Gao Z.P., Zhu B.Y., Huang H.L., et al. Heat shock protein 90 acts as a molecular chaperone in late-phase activation of extracellular signal-regulated kinase 1/2 stimulated by oxidative stress in vascular smooth muscle cells. Acta Pharmacol. Sin. 2007, 28:1907-1913.
189. Joseph K., Tholanikunnel B.G., Kaplan A.P. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc. Natl. Acad. Sci. USA 2002, 99:896-900.
190. Duchene J., Ahluwalia A. The kinin B(1) receptor and inflammation: new therapeutic target for cardiovascular disease. Curr. Opin. Pharmacol. 2009, 9:125-131.
191. Chen J.H., Riazy M., Smith E.M., Proud C.G., Steinbrecher U.P., Duronio V. Oxidized LDL-mediated macrophage survival involves elongation factor-2 kinase. Arterioscler. Thromb. Vasc. Biol. 2009, 29:92-98.
192. Lin L.Y., Lin C.Y., Ho F.M., Liau C.S. Up-regulation of the association between heat shock protein 90 and endothelial nitric oxide synthase prevents high glucose-induced apoptosis in human endothelial cells. J. Cell. Biochem. 2005, 94:194-201.
193. Antonova G.N., Snead C.M., Antonov A.S., Dimitropoulou C., Venema R.C., Catravas J.D. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H893-H903.
194. Haendeler J., Hoffmann J., Rahman S., Zeiher A.M., Dimmeler S. Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation. FEBS Lett. 2003, 536:180-186.
195. Zhang R., Luo D., Miao R., Bai L., Ge Q., Sessa W.C., et al. Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. Oncogene 2005, 24:3954-3963.
196. Davis B.J., Xie Z., Viollet B., Zou M.H. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006, 55:496-505.
197. Rezzani R., Rodella L., Dessy C., Daneau G., Bianchi R., Feron O. Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium. FEBS Lett. 2003, 552:125-129.
198. Aschner J.L., Zeng H., Kaplowitz M.R., Zhang Y., Slaughter J.C., Fike C.D. Heat shock protein 90-eNOS interactions mature with postnatal age in the pulmonary circulation of the piglet. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296:L555-L564.
199. Harris M.B., Mitchell B.M., Sood S.G., Webb R.C., Venema R.C. Increased nitric oxide synthase activity and Hsp90 association in skeletal muscle following chronic exercise. Eur. J. Appl. Physiol. 2008, 104:795-802.
200. Bucci M., Roviezzo F., Posadas I., Yu J., Parente L., Sessa W.C., et al. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc. Natl. Acad. Sci. USA 2005, 102:904-908.
201. Lancaster G.I., Febbraio M.A. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J. Biol. Chem. 2005, 280:23349-23355.
202. Gupta S., Knowlton A.A. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H3052-H3056.
203. Schett G., Xu Q., Amberger A., van der Zee R., Recheis H., Willeit J., et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J. Clin. Invest. 1995, 96:2569-2577.
204. Schett G., Metzler B., Mayr M., Amberger A., Niederwieser D., Gupta R.S., et al. Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis 1997, 128:27-38.
205. Kol A., Sukhova G.K., Lichtman A.H., Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998, 98:300-307.
206. Kol A., Lichtman A.H., Finberg R.W., Libby P., Kurt-Jones E.A. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J. Immunol. 2000, 164:13-17.
207. Xu Q., Dietrich H., Steiner H.J., Gown A.M., Schoel B., Mikuz G., et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler. Thromb. 1992, 12:789-799.
208. Foteinos G., Afzal A.R., Mandal K., Jahangiri M., Xu Q. Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage. Circulation 2005, 112:1206-1213.
209. Dieude M., Gillis M.A., Theoret J.F., Thorin E., Lajoie G., Levine J.S., et al. Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis. J. Thromb. Haemost. 2009, 7:710-719.
210. Johnson A.D., Berberian P.A., Tytell M., Bond M.G. Atherosclerosis alters the localization of HSP70 in human and macaque aortas. Exp. Mol. Pathol. 1993, 58:155-168.
211. Tytell M., Greenberg S.G., Lasek R.J. Heat shock-like protein is transferred from glia to axon. Brain Res. 1986, 363:161-164.
212. Johnson A.D., Tytell M. Exogenous HSP70 becomes cell associated, but not internalized, by stressed arterial smooth muscle cells. In Vitro Cell. Dev. Biol. Anim. 1993, 29A:807-812.
213. Zhu W., Roma P., Pirillo A., Pellegatta F., Catapano A.L. Human endothelial cells exposed to oxidized LDL express hsp70 only when proliferating. Arterioscler. Thromb. Vasc. Biol. 1996, 16:1104-1111.
214. van W.F., Prakken B. Heat shock proteins: Darwinistic immune modulation on dangerous grounds. J. Leukoc. Biol. 2010, 88:431-434.
215. Currie R.W., Karmazyn M., Kloc M., Mailer K. Heat-shock response is associated with enhanced postischemic ventricular recovery. Circ. Res. 1988, 63:543-549.
216. Currie R.W., Karmazyn M. Improved post-ischemic ventricular recovery in the absence of changes in energy metabolism in working rat hearts following heat-shock. J. Mol. Cell. Cardiol. 1990, 22:631-636.
217. Karmazyn M., Mailer K., Currie R.W. Acquisition and decay of heat-shock-enhanced postischemic ventricular recovery. Am. J. Physiol. 1990, 259:H424-H431.
218. Okada M., Hasebe N., Aizawa Y., Izawa K., Kawabe J., Kikuchi K. Thermal treatment attenuates neointimal thickening with enhanced expression of heat-shock protein 72 and suppression of oxidative stress. Circulation 2004, 109:1763-1768.
219. Brasselet C., Durand E., Addad F., Vitry F., Chatellier G., Demerens C., et al. Effect of local heating on restenosis and in-stent neointimal hyperplasia in the atherosclerotic rabbit model: a dose-ranging study. Eur. Heart J. 2008, 29:402-412.
220. Kihara T., Biro S., Imamura M., Yoshifuku S., Takasaki K., Ikeda Y., et al. Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure. J. Am. Coll. Cardiol. 2002, 39:754-759.
221. Imamura M., Biro S., Kihara T., Yoshifuku S., Takasaki K., Otsuji Y., et al. Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J. Am. Coll. Cardiol. 2001, 38:1083-1088.
222. Jayakumar J., Suzuki K., Khan M., Smolenski R.T., Farrell A., Latif N., et al. Gene therapy for myocardial protection: transfection of donor hearts with heat shock protein 70 gene protects cardiac function against ischemia-reperfusion injury. Circulation 2000, 102:III302-III306.
223. Jayakumar J., Suzuki K., Sammut I.A., Smolenski R.T., Khan M., Latif N., et al. Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation 2001, 104:I303-I307.
224. Matsumoto M., Dimayuga P.C., Wang C., Kirzner J., Cercek M., Yano J., et al. Exogenous heat shock protein-70 inhibits cigarette smoke-induced intimal thickening. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R1320-R1327.
225. Anazawa T., Dimayuga P.C., Li H., Tani S., Bradfield J., Chyu K.Y., et al. Effect of exposure to cigarette smoke on carotid artery intimal thickening: the role of inducible NO synthase. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1652-1658.
226. Tani S., Dimayuga P.C., Anazawa T., Chyu K.Y., Li H., Shah P.K., et al. Aberrant antibody responses to oxidized LDL and increased intimal thickening in apoE-/- mice exposed to cigarette smoke. Atherosclerosis 2004, 175:7-14.
227. Connolly E.M., Kelly C.J., Chen G., O'grady T., Kay E., Leahy A., et al. Pharmacological induction of HSP27 attenuates intimal hyperplasia in vivo. Eur. J. Vasc. Endovasc. Surg. 2003, 25:40-47.
228. Liu Y.N., Pan S.L., Peng C.Y., Guh J.H., Huang D.M., Chang Y.L., et al. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9. J. Pharmacol. Exp. Ther. 2006, 316:35-41.
229. Kummar S., Gutierrez M.E., Gardner E.R., Chen X., Figg W.D., Zajac-Kaye M., et al. Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Eur. J. Cancer 2010, 46:340-347.
230. Ramanathan R.K., Egorin M.J., Erlichman C., Remick S.C., Ramalingam S.S., Naret C., et al. Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors. J. Clin. Oncol. 2010, 28:1520-1526.
231. Lancet J.E., Gojo I., Burton M., Quinn M., Tighe S.M., Kersey K., et al. Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. Leukemia 2010, 24:699-705.
232. Pacey S., Gore M., Chao D., Banerji U., Larkin J., Sarker S., et al. A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma. Invest. New Drugs 2010.
233. Biamonte M.A., Van de Water R., Arndt J.W., Scannevin R.H., Perret D., Lee W.C. Heat shock protein 90: inhibitors in clinical trials. J. Med. Chem. 2010, 53:3-17.
234. Uchiyama T., Atsuta H., Utsugi T., Ohyama Y., Nakamura T., Nakai A., et al. Simvastatin induces heat shock factor 1 in vascular endothelial cells. Atherosclerosis 2006, 188:265-273.
235. Niu G., Chen X. From protein-protein interaction to therapy response: molecular imaging of heat shock proteins. Eur. J. Radiol. 2009, 70:294-304.
236. Benagiano M., D'Elios M.M., Amedei A., Azzurri A., van der Zee R., Ciervo A., et al. Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J. Immunol. 2005, 174:6509-6517.
237. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1547-1559.
238. Harats D., Yacov N., Gilburd B., Shoenfeld Y., George J. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J. Am. Coll. Cardiol. 2002, 40:1333-1338.
239. Huber S.A., Sakkinen P., David C., Newell M.K., Tracy R.P. T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 2001, 103:2610-2616.
240. Maron R., Sukhova G., Faria A.M., Hoffmann E., Mach F., Libby P., et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002, 106:1708-1715.
241. van Puijvelde G.H., van E.T., van Wanrooij E.J., Habets K.L., de V.P., van der Zee R. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2677-2683.
242. Xiong Q., Li J., Jin L., Liu J., Li T. Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms. Immunol. Lett. 2009, 125:40-45.
243. Van E.W., Wick G., Albani S., Cohen I. Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Ann. NY Acad. Sci. 2007, 1113:217-237.